Synergistic effect of combined HMG-CoA reductase inhibitor and angiotensin-II receptor blocker therapy in patients with chronic heart failure: the HF-COSTAR trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples